Clover Health Investments, Corp. (CLOV)

NASDAQ: CLOV · Real-Time Price · USD
3.940
-0.120 (-2.96%)
At close: Oct 22, 2024, 4:00 PM
3.930
-0.010 (-0.25%)
Pre-market: Oct 23, 2024, 7:00 AM EDT
-2.96%
Market Cap 1.96B
Revenue (ttm) 2.09B
Net Income (ttm) -123.70M
Shares Out 497.47M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,306,278
Open 4.010
Previous Close 4.060
Day's Range 3.820 - 4.085
52-Week Range 0.606 - 4.710
Beta 2.14
Analysts Hold
Price Target 4.00 (+1.52%)
Earnings Date Nov 4, 2024

About CLOV

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee. [Read more]

Sector Healthcare
Founded 2014
Employees 552
Stock Exchange NASDAQ
Ticker Symbol CLOV
Full Company Profile

Financial Performance

In 2023, Clover Health Investments's revenue was $2.04 billion, a decrease of -43.11% compared to the previous year's $3.58 billion. Losses were -$213.36 million, -37.17% less than in 2022.

Financial Statements

Analyst Forecast

According to one analyst, the rating for CLOV stock is "Hold" and the 12-month stock price forecast is $4.0.

Price Target
$4.0
(1.52% upside)
Analyst Consensus: Hold
Stock Forecasts

News

2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors

Company's affordable, benefit-rich flagship PPO plans now have 4 Star rating Company's affordable, benefit-rich flagship PPO plans now have 4 Star rating

7 days ago - GlobeNewsWire

Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025

Overall Star rating performance increase was driven by exceptional performance on healthcare quality measures, Medication Adherence and Member Experience Overall Star rating performance increase was d...

12 days ago - GlobeNewsWire

Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer

Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Health Dr. Tsay Brings Unique Expertise in AI, Digital Health, and Clinical Innovation to Counterpart Hea...

15 days ago - GlobeNewsWire

Undercovered Dozen: Clover Health, Quipt, Vital Energy, STMicroelectronics +

The 'Undercovered' Dozen highlights 12 lesser-covered stocks with strong potential, aiming to provide investment ideas and spark community discussion. Dmytro Konovalov takes a look at the impacts of T...

Other symbols: STMVTLE
18 days ago - Seeking Alpha

Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations

New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients New Jersey Native Joseph Brand to Lead Operational Efficiency ...

26 days ago - GlobeNewsWire

The Iowa Clinic Signs Multi-Year Agreement with Counterpart Health to Deploy Proven AI Technology to Hundreds of Providers Across the Midwest

FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, Counterpart Health, Inc . (“Counterpart”), a leading AI-powered physician enablement platform, announced a multi-year agreement with The Iowa...

7 weeks ago - GlobeNewsWire

Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference

FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to ...

2 months ago - GlobeNewsWire

Clover Health: A Profitable Future Ahead Fueled By AI And Star Rating Success

Clover Health Investments posted its first profitable quarter as a public company and raised its full-year guidance in Q2. Clover Health's star rating increased by 0.5 stars, which could have a positi...

2 months ago - Seeking Alpha

Clover Health Investments, Corp. (CLOV) Q2 2024 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Peter Kuipers - CFO Conference Call P...

2 months ago - Seeking Alpha

Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance

Total Revenue growth for the Second Quarter of 2024 of 11% year-over-year GAAP Net Income from Continuing Operations during the Second Quarter of 2024 of $7.2 million versus Second Quarter 2023 GAAP l...

2 months ago - GlobeNewsWire

Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference

FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to ...

3 months ago - GlobeNewsWire

Clover Health to Report Second Quarter 2024 Financial Results on August 5

FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to great he...

3 months ago - GlobeNewsWire

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement

FRANKLIN, Tenn., June 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to ...

4 months ago - GlobeNewsWire

CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year

The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that ra...

4 months ago - GlobeNewsWire

The 'Undercovered' Dozen From June 1-6

The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Biotechs CRISPR Therapeutics, Voyager Therapeutics, and Alnylam Pharmaceuticals are covered al...

4 months ago - Seeking Alpha

Clover Health: New Business Model Is A Game Changer

Clover Health is making its AI-powered technology platform, Clover Assistant, available for other Medicare Advantage payors and providers under the brand name Counterpart Assistant. The new offering w...

4 months ago - Seeking Alpha

Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers

FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to b...

5 months ago - GlobeNewsWire

Here's why Clover Health stock price spiked after earnings

Clover Health (NASDAQ: CLOV) stock price went parabolic on Wednesday as investors cheered the company's financial results, forward guidance, and share repurchase program. It surged by over 18%, its be...

5 months ago - Invezz

Clover Health Investments, Corp. (CLOV) Q1 2024 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Terrence Ronan - Interim CFO Conference ...

6 months ago - Seeking Alpha

Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

FRANKLIN, Tenn., April 30, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”), a physician enablement technology company committed to bringing access ...

6 months ago - GlobeNewsWire

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024...

6 months ago - GlobeNewsWire

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer

FRANKLIN, Tenn., April 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company, today annou...

6 months ago - GlobeNewsWire

Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions

FRANKLIN, Tenn., April 04, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, most recently in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and in its Quarterly Report on...

7 months ago - GlobeNewsWire

Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness

Partnership aims to improve outcomes through increased support to underserved and at-risk patient populations through Clover's home-based care model Partnership aims to improve outcomes through increa...

7 months ago - GlobeNewsWire

Clover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call Transcript

Clover Health Investments, Corp. (CLOV) Q4 2023 Earnings Call Transcript

8 months ago - Seeking Alpha